Results 221 to 230 of about 67,770 (262)

Sarcopenia and its risk factors in epidemiological study

, 2012
Hiroshi Shimokata, Fujiko Ando
openalex   +2 more sources

An Attention-Aware Multi-Task Learning Framework Identifies Candidate Targets for Drug Repurposing in Sarcopenia. [PDF]

J Cachexia Sarcopenia Muscle
Reza MS, Qiu C, Lin X, Su KJ, Liu A, Zhang X, Gong Y, Luo Z, Tian Q, Nwadiugwu M, Liang S, Shen H, Deng HW.   +12 more
europepmc   +1 more source

Impact of the visceral adipose tissue on bone quality in patients with untreated mild‐to‐severe obstructive sleep apnea

Journal of Sleep Research, EarlyView.
Summary Obstructive sleep apnea (OSA) predominantly affects patients who are obese and causes systemic organ damage. Little is known about the relationship between fat distribution and bone impairment in these patients. We aimed to evaluate the impact of the visceral adipose tissue (VAT) on the bone quality of patients with OSA.
Giulia Sartori, Francesco Bertoldo, Andrea Gretter, Federica Margherita Lovati, Rosaria Caprino, Giovanni Viterale, Ernesto Crisafulli   +6 more
wiley   +1 more source

Nonleisure-time physical activity as a protective factor against sarcopenia in hemodialysis patients: a prospective cohort study. [PDF]

Front Nutr
Chang L, Zheng Y, Ding Y, Long Z, Zhang H.   +4 more
europepmc   +1 more source

How do glucagon‐like Peptide‐1 receptor agonists affect measures of muscle mass in individuals with, and without, type 2 diabetes: A systematic review and meta‐analysis

Obesity Reviews, EarlyView.
Summary Glucagon‐like peptide‐1 receptor agonists (GLP1RAs) are used for the management of type 2 diabetes (T2DM) and obesity. GLP1RAs induce significant weight loss but concerns have been raised regarding the associated effects on muscle mass (MM). We therefore conducted a systematic review and meta‐analysis assessing the effects of GLP1RAs on various
Oluwaseun Anyiam, Arash Ardavani, Rushdina Sofia Abdul Rashid, Avinash Panesar, Iskandar Idris   +4 more
wiley   +1 more source

Plasma Extracellular Vesicles Biomarkers Linked to Lower Muscle Mass, Function and Physical Performance in Sarcopenia. [PDF]

J Cachexia Sarcopenia Muscle
Kim JY, Gil TH, Lee HG, Shin JW, Jang DH, Kim HS, Park SS, Kim SW, Shin CS, Kong SH, Jeon OH.   +10 more
europepmc   +1 more source

Impact of Paraspinal Sarcopenia on Clinical Outcomes in Intervertebral Disc Degeneration Patients Following Percutaneous Transforaminal Endoscopic Lumbar Discectomy

Orthopaedic Surgery, EarlyView.
This study explores paraspinal muscle degeneration and fat infiltration in sarcopenic patients, analyzing their postoperative outcomes after disc excision. Through multifactorial regression analysis, we identify key factors affecting postoperative low back pain, emphasizing the need for improved nutrition and exercise in managing sarcopenia.
Tianci Fang, Zhifang Xue, Quan Zhou, Jiawen Gao, Jian Mi, Huilin Yang, Feng Zhou, Hao Liu, Junxin Zhang   +8 more
wiley   +1 more source

Mid- and long-term associations between food insecurity and sarcopenia. [PDF]

Aging Clin Exp Res
Salinas-Rodríguez A, De la Cruz-Góngora V, Manrique-Espinoza B.   +2 more
europepmc   +1 more source

The Cervical Vertebral Bone Quality Score Is a Novel Reliable Index Reflecting the Condition of Paraspinal Muscles and Predicting Loss of Cervical Lordosis After Open‐Door Laminoplasty

Orthopaedic Surgery, EarlyView.
There is a close correlation between C‐VBQ scores and the cervical deep extensors, deep flexors, and overall paraspinal muscles relative cross‐sectional area (RCSA) and degree of fat infiltration (DFF). The C‐VBQ score is a comprehensive parameter reflecting the quality of cervical bone and paraspinal muscles.
Junhu Li, Xingxia Long, Linnan Wang, Qiujiang Li, Lei Wang, Yueming Song   +5 more
wiley   +1 more source

The influencing factors of tumor-related sarcopenia: a scoping review. [PDF]

BMC Cancer
Tian C, Li N, Gao Y, Yan Y.
europepmc   +1 more source